Coloplast Stock - Wednesday snapshot with consensus and valuation context

Coloplast stock trades without a fresh corporate catalyst this Wednesday, leaving investors to focus on consensus expectations, valuation levels and the Danish medtech group’s chronic care positioning in a still defensive healthcare sector.

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 16:10 UTC. Details in the imprint.

Coloplast (DK0060448595) remains a steady healthcare name midweek as no new earnings releases, rating changes or corporate actions have been published by the company or major wires in the past 24 hours according to a review of recent disclosures.

What recent coverage shows

A review of company communications and major financial media does not reveal a fresh Coloplast earnings release, guidance change or management announcement dated this week, underscoring a quiet news backdrop for the Danish medtech group.

An earlier overview from ad hoc news already highlighted that June 16, 2026 brought no new US-focused earnings or rating actions on Coloplast, and this lack of a single-day catalyst broadly persists into Wednesday.

Analyst views and fair value markers

Despite the calm news flow, investors still watch analyst valuation markers. Simply Wall St recently cited a fair-value estimate around DKK 462 per share for Coloplast based on updated assumptions, alongside mention of a new FDA approval for the Titan Prime implant.

That analysis also noted that target cuts from some houses had been offset by at least one new Buy initiation, leaving the average modeled value only slightly adjusted and pointing to modest growth and margin expectations rather than aggressive forecasts.

The product behind the stock

Coloplast generates most of its revenue from chronic-care medical products, notably ostomy care appliances, continence care solutions, advanced wound dressings and urology products that support long-term treatment of patients in hospitals, nursing homes and home-care settings.

Where the stock trades today

The shares of Coloplast (DK0060448595) trade on Nasdaq Copenhagen at DKK 380.00 as of 06/17/2026, 15:55 CET.

Coloplast at a glance

• Company: Coloplast A/S
• ISIN: DK0060448595
• WKN: A1KAGC
• Ticker: COLO-B
• Venue: Nasdaq Copenhagen
• Price (as of 06/17/2026, 15:55 CET): 380.00 DKK
• Market cap: 205,000,000,000 DKK (as of 06/17/2026)
• Sector / Industry: Healthcare - Medical Devices, Chronic Care
• Index membership: Included in key European benchmarks such as the Euronext Europe 500.
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.